PLOS is a non-profit organization on a mission to drive open science forward with measurable, meaningful change in research publishing, policy, and practice.

Building on a strong legacy of pioneering innovation, PLOS continues to be a catalyst, reimagining models to meet open science principles, removing barriers and promoting inclusion in knowledge creation and sharing, and publishing research outputs that enable everyone to learn from, reuse and build upon scientific knowledge.

We believe in a better future where science is open to all, for all.

Journals
More Content
PLOS BLOGS Speaking of Medicine and Health
Browse all PLOS Blogs
Browse all PLOS Blogs

PLOS Medicine Podcast episode 1: The Actionable Cancer Genome

PLOS Medicine Call for Papers Cancer

PLOS Medicine’s Senior Research Editor Clare Garvey interviews Elaine Mardis and Marc Ladanyi, Guest Editors for our Special Issue on the Actionable Cancer Genome

 

elainemardis2
Elaine Mardis
ladanyi-marc_0
Marc Ladanyi

Elaine Mardis is co-Director of the McDonnell Genome Institute and Robert E. and Louise F. Dunn Distinguished Professor of Medicine at Washington University.

Marc Ladanyi is Chief of Molecular Diagnostic Service and William J. Ruane Chaire in Molecular Oncology at Memorial Sloan Kettering Cancer Center.

 

 

Listen above to hear Elaine and Marc discuss:

  • Insights into novel approaches such as immunotherapies as well as acquired resistance.
  • Clinical trials approaches in the cancer genome era
  • Funding: The recent moonshot announcement versus traditional streams
  • Timelines of recent advances and future areas of development
  • Translating cancer genomics information into better and first line therapies for patients

Read the Call for Papers and submit your research by July 8!

Featured image: an osteosarcoma cell with DNA in blue, energy factories (mitochondria) in yellow, and actin filaments, part of the cellular skeleton, in purple. Image credit: Dylan Burnette and Jennifer Lippincott-Schwartz, NCI.

Back to top